Last reviewed · How we verify

NCT06061562: TAPAS

Down Syndrome, Physical Activity and Sleep Apnea

Recruiting now Last updated 17 January 2024
What this trial tests

trial in Down Syndrome in 50 participants. Currently enrolling.

Timeline
11 January 2024
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorUniversity Hospital, Grenoble
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date11 January 2024
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Grenoble

Who can join

6 and older, any sex, with Down Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To realize a sleep phenotyping in a population with Down syndrome, its determinants, and the consequences of these disorders, with a specific focus on sleep apnea syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Down Syndrome

Currently open trials in the same condition.

Other University Hospital, Grenoble trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06061562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing